We are live on ! Find out more
ENVB icon

Enveric Biosciences
ENVB

1 hedge funds and large institutions have $90K invested in Enveric Biosciences in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more capital invested

Capital invested by funds: $15K → $90K (+$75K)

1.66% more ownership

Funds ownership: 0.65% → 2.31% (+1.7%)

Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ENVB Hedge Fund Activity: Q2 2020 in Review

1 of the 4,889 institutional investors tracked by Wall St. Rank reported a position in Enveric Biosciences (ENVB) for Q2 2020, worth a combined $90K — up 500% from $15K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new ENVB positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Enveric Biosciences (ENVB) as of Q2 2020, up from 0 in Q1 2020.
  • Funds reported $90K of Enveric Biosciences stock for Q2 2020, up 500% quarter-over-quarter.
  • 1 fund opened new Enveric Biosciences positions in Q2 2020 and 0 closed out, a net change of +1 holder.

Based on aggregated 13F filings for Q2 2020.